110 related articles for article (PubMed ID: 10493982)
1. Vascular retardation in dormant growth-stunted malignant melanomas.
Piérard-Franchimont C; Henry F; Heymans O; Piérard GE
Int J Mol Med; 1999 Oct; 4(4):403-6. PubMed ID: 10493982
[TBL] [Abstract][Full Text] [Related]
2. Quantification of vascularity in nodular melanoma and Spitz's nevus.
Binder M; Steiner A; Mossbacher U; Hunegnaw M; Wolff K; Pehamberger H
J Cutan Pathol; 1997 May; 24(5):272-7. PubMed ID: 9194579
[TBL] [Abstract][Full Text] [Related]
3. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas.
Piérard GE; Piérard-Franchimont C
Eur J Cancer; 1997 Oct; 33(11):1888-92. PubMed ID: 9470852
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.
Srivastava A; Laidler P; Davies RP; Horgan K; Hughes LE
Am J Pathol; 1988 Nov; 133(2):419-23. PubMed ID: 3189515
[TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis.
Massi D; Franchi A; Borgognoni L; Paglierani M; Reali UM; Santucci M
Virchows Arch; 2002 Jan; 440(1):22-8. PubMed ID: 11942572
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
7. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness.
Carnochan P; Briggs JC; Westbury G; Davies AJ
Br J Cancer; 1991 Jul; 64(1):102-7. PubMed ID: 1854608
[TBL] [Abstract][Full Text] [Related]
8. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
9. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
[TBL] [Abstract][Full Text] [Related]
10. Influence of tumor thickness and vascularity on survival in cutaneous melanoma.
Zamolo G; Gruber F; Cabrijan L; Micović V; Iternicka Z; Jonjić N
Acta Med Okayama; 2001 Oct; 55(5):289-93. PubMed ID: 11688952
[TBL] [Abstract][Full Text] [Related]
11. Dermal vascularity in lentigo maligna.
Trotter MJ; Tron VA
J Pathol; 1994 Aug; 173(4):341-5. PubMed ID: 7525908
[TBL] [Abstract][Full Text] [Related]
12. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin.
Busam KJ; Berwick M; Blessing K; Fandrey K; Kang S; Karaoli T; Fine J; Cochran AJ; White WL; Rivers J
Am J Pathol; 1995 Oct; 147(4):1049-56. PubMed ID: 7573350
[TBL] [Abstract][Full Text] [Related]
13. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study.
Srivastava A; Laidler P; Hughes LE; Woodcock J; Shedden EJ
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1205-9. PubMed ID: 2434333
[TBL] [Abstract][Full Text] [Related]
14. Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.
Barnhill RL; Levy MA
Am J Pathol; 1993 Jul; 143(1):99-104. PubMed ID: 7686347
[TBL] [Abstract][Full Text] [Related]
15. The vascularity of primary cutaneous melanoma.
Fallowfield ME; Cook MG
J Pathol; 1991 Jul; 164(3):241-4. PubMed ID: 1890549
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic fast-growing melanomas and their micrometastases.
Quatresooz P; Pierard-Franchimont C; Paquet P; Pierard GE
Eur J Dermatol; 2010; 20(3):302-7. PubMed ID: 20413369
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen.
Guffey JM; Chaney JV; Stevens GL; Schroer KR; Fenske NA; Reintgen D; Glass LF
J Cutan Pathol; 1995 Apr; 22(2):122-7. PubMed ID: 7560343
[TBL] [Abstract][Full Text] [Related]
18. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behaviour.
Srivastava A; Hughes LE; Woodcock JP; Laidler P
Br J Cancer; 1989 Jan; 59(1):89-91. PubMed ID: 2667611
[TBL] [Abstract][Full Text] [Related]
19. Analysis and significance of the malignant 'eclipse' during the progression of primary cutaneous human melanomas.
Kerbel RS; Kobayashi H; Graham CH; Lu C
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):183-7. PubMed ID: 9627714
[TBL] [Abstract][Full Text] [Related]
20. The significance of blood flow in cutaneous malignant melanoma demonstrated by Doppler flowmetry.
Srivastava A; Hughes LE; Woodcock JP; Shedden EJ
Eur J Surg Oncol; 1986 Mar; 12(1):13-8. PubMed ID: 2420648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]